Activation of inflammasome by attenuatedSalmonella typhimuriumin bacteria-mediated cancer therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of inflammasome by attenuatedSalmonella typhimuriumin bacteria-mediated cancer therapy
Authors
Keywords
-
Journal
MICROBIOLOGY AND IMMUNOLOGY
Volume 59, Issue 11, Pages 664-675
Publisher
Wiley
Online
2015-10-24
DOI
10.1111/1348-0421.12333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β
- (2015) Jung-Eun Kim et al. Theranostics
- Anti-Tumoral Effect of the Mitochondrial Target Domain of Noxa Delivered by an Engineered Salmonella typhimurium
- (2014) Jae-Ho Jeong et al. PLoS One
- Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent
- (2013) Sheng-Nan Jiang et al. MOLECULAR THERAPY
- A Novel Balanced-Lethal Host-Vector System Based on glmS
- (2013) Kwangsoo Kim et al. PLoS One
- New paradigm for tumor theranostic methodology using bacteria-based microrobot
- (2013) Sung Jun Park et al. Scientific Reports
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- Sensing and reacting to microbes through the inflammasomes
- (2012) Luigi Franchi et al. NATURE IMMUNOLOGY
- ATP Release from Dying Autophagic Cells and Their Phagocytosis Are Crucial for Inflammasome Activation in Macrophages
- (2012) Gizem Ayna et al. PLoS One
- The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
- (2011) Beckley K. Davis et al. Annual Review of Immunology
- NLRP3 inflammasomes link inflammation and metabolic disease
- (2011) Dominic De Nardo et al. TRENDS IN IMMUNOLOGY
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
- (2010) L. Aymeric et al. CANCER RESEARCH
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- The NLRP3 inflammasome, a target for therapy in diverse disease states
- (2010) Graham P. Cook et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin
- (2010) Matam Vijay-Kumar et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibition of Tumor Growth and Metastasis by a Combination of Escherichia coli –mediated Cytolytic Therapy and Radiotherapy
- (2010) Sheng-Nan Jiang et al. MOLECULAR THERAPY
- Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome
- (2010) E. A. Miao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-1β Processing in Host Defense: Beyond the Inflammasomes
- (2010) Mihai G. Netea et al. PLoS Pathogens
- Genetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer
- (2009) V. H. Nguyen et al. CANCER RESEARCH
- Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
- (2009) Sara Leschner et al. PLoS One
- Extracellular ATP in the Immune System: More Than Just a "Danger Signal"
- (2009) A. Trautmann Science Signaling
- Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals
- (2008) Jung-Joon Min et al. Nature Protocols
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started